An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Phreesia’s Zeeshan Butt Named to NQF’s MAP Clinician Workgroup
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Phreesia announced that Zeeshan Butt, PhD, has been appointed to the National Quality Forum’s Measure Applications Partnership (MAP) Clinician Workgroup for a three-year term. This group influences performance measures for federal public reporting and payment programs. Dr. Butt is a licensed clinical health psychologist specializing in patient-reported outcomes. Phreesia supports over 100 million patient visits annually, offering tools that enhance health outcomes and efficiency in healthcare settings. Its Patient Activation Measure® is recognized for improving clinical results and reducing costs.
Positive
Dr. Zeeshan Butt appointed to a prestigious role, enhancing Phreesia's influence in healthcare quality measures.
The Patient Activation Measure® endorsed by the NQF, demonstrating its effectiveness in improving patient outcomes and reducing costs.
Phreesia facilitates over 100 million patient visits annually, highlighting its robust market presence.
Negative
None.
WILMINGTON, Del.--(BUSINESS WIRE)--
Phreesia is proud to announce that Zeeshan Butt, PhD, a Director of Clinical Content, has been selected to serve a three-year term as a member of the National Quality Forum (NQF)’s Measure Applications Partnership (MAP) 2022-2023 Clinician Workgroup.
NQF convened MAP in 2011, in partnership with the Centers for Medicare & Medicaid Services (CMS), to provide input to the U.S. Department of Health and Human Services (HHS) on the selection of performance measures for public reporting and performance-based payment programs. MAP is a diverse, multi-stakeholder group that includes leaders and experts from health plans, suppliers, provider organizations, community health agencies and other entities.
The Clinician Workgroup will provide recommendations on issues related to the selection and coordination of measures that would impact clinicians, particularly in the office setting, such as those in the Merit-Based Incentive Payment System (MIPS).
Dr. Butt is a licensed clinical health psychologist and Phreesia’s resident expert in patient-reported outcomes (PROs) and clinical quality measurement. At Phreesia, he works closely with health systems and provider groups to help them implement screening tools and PROs, improve health outcomes and meet quality goals.
“As a health psychologist, I am honored to have been invited to join as a subject matter expert and member of this workgroup,” said Dr. Butt. “I believe our work will help to amplify the voice of clinicians toward the selection of performance measures for federal public reporting, performance-based payment and other health programs.”
Phreesia facilitates more than 100 million visits a year. Its intake platform offers healthcare providers the ability to collect key patient-reported data, and Phreesia is also the steward of the Patient Activation Measure® (PAM®), a survey that assesses patients’ underlying knowledge, skills and confidence to manage their own health. PAM is backed by research demonstrating that higher scores are associated with better clinical outcomes, higher patient satisfaction with care and lower healthcare costs. PAM has also been successfully used as a performance metric, PAM-PM, which has been endorsed by the NQF.
About Phreesia
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform activates patients in their healthcare and provides a modern, convenient experience, while enabling our clients to enhance clinical care and drive efficiency.
Who is Zeeshan Butt and what is his role at Phreesia?
Zeeshan Butt, PhD, is the Director of Clinical Content at Phreesia, focused on patient-reported outcomes and quality measurement.
What is the Measure Applications Partnership and its significance?
The Measure Applications Partnership (MAP) provides recommendations to guide the selection of performance measures for federal health programs.
How does Phreesia's Patient Activation Measure® impact healthcare?
The Patient Activation Measure® improves clinical outcomes and reduces healthcare costs by assessing patients' abilities to manage their health.
What are the benefits of Phreesia's intake platform?
Phreesia's platform enhances patient engagement and clinical efficiencies by allowing healthcare providers to collect important patient-reported data effectively.
What is Phreesia's market presence in terms of patient visits?
Phreesia manages over 100 million patient visits annually, indicating a strong presence in the healthcare sector.
